Abstract
IN the past few years an increasing interest has developed in the determination of urinary hydroxyproline as an index of the metabolism and turnover of collagen. Recent experimental1 , 2 and clinical studies3 4 5 6 7 8 9 10 11 12 13 14 15 16 performed in normal as well as in many endocrine, metabolic and bone diseases have indicated that bone collagen is the major source of this amino acid in urine. The present investigation was undertaken to study the excretion of total urinary hydroxyproline in patients with inoperable or widespread carcinoma, especially those with bone metastases or hypercalcemia or both. Our specific aim was to observe what relation exists between urinary excretion . . .
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
